Tirzepatide provider cost is mostly hidden math. The sticker price you see almost never includes the membership fee, the lab work, or the price jump that hits when you reach your real maintenance dose. This breakdown shows what 20-plus named telehealth brands and compounding pharmacies actually charge per month, which ones are legitimate, and the single cheapest cash-pay path.
Quick Answer
Tirzepatide provider cost runs from about $125 to $699 a month, driven by two things: whether you choose compounded tirzepatide or brand Zepbound, and whether the provider folds its membership fee into the price or bills it separately. The cheapest legitimate cash-pay route is a flat, all-in compounded plan that uses a named US pharmacy and a real prescriber. Brand Zepbound vials through LillyDirect self-pay run $299 to $449 a month with no insurance, and the Lilly Savings Card can drop covered brand prescriptions to roughly $25 a month.
🔑 Key Takeaways
- Read the all-in price, not the headline. Your true monthly cost is medication plus membership plus labs. Many roundups quote the medication only and bury the recurring fee.
- Compounded tirzepatide runs roughly $125 to $699 a month. Brand Zepbound vials through LillyDirect self-pay run $299 to $449 a month with no insurance.
- Flat, all-dose pricing beats the dose-tier trap. Many providers advertise a low 2.5mg price, then charge more at the 10mg to 15mg maintenance dose that actually drives results.
- Tirzepatide costs $50 to $150 more than semaglutide because it is a dual GIP/GLP-1 agonist, a more complex molecule than semaglutide.
- Legitimacy hinges on a named US pharmacy, a licensed prescriber, and batch testing, not on who posts the lowest number.
Here is how the leading telehealth providers stack up at a glance. Pricing reflects all-in monthly cost where the provider discloses it.
Tirzepatide provider cost comparison: 20+ brands
Most lists profile six names. Searchers want the long tail too, the per-brand and per-pharmacy rows that competitors skip. Below is one anchored row per provider, with the all-in monthly cost where it is disclosed, the medication type, the membership fee, and a quick legitimacy read. Cash-pay prices change often, so confirm at consult.
| Provider | Type | All-in monthly cost | Membership fee | Legitimacy read |
|---|---|---|---|---|
| Yucca Health | Compounded | $146 to $258 | None (bundled) | Named US pharmacy, doctor-supervised |
| LillyDirect (Zepbound) | Brand (Eli Lilly) | $299 to $449 | None | Manufacturer-direct, highest trust |
| MEDVi | Brand + compounded | $99 to $399 | None | Brand and compounded, no membership |
| Trimi | Compounded | ~$125 flat | None | Flat all-dose; paused compounded supply during FDA enforcement |
| Henry Meds | Compounded (oral + injectable) | $297 to $349 ($99 to $119 starter) | Bundled | Named pharmacy, heavily reviewed |
| Mochi Health | Compounded | ~$278 all-in (or $199 to $299) | $79/mo | Insurance-friendly, large patient base |
| Ro (Ro Body) | Brand Zepbound | Up to ~$544 ($145 to $149 + $299 vials) | $145 to $149/mo | Established, brand-only path |
| Hims & Hers | Brand Zepbound + compounded | From ~$448 ($149 + from $299) | $149/mo ($39 first month) | Public company, brand path |
| Remedy Meds | Compounded | $399 | None | No membership, flat pricing |
| Eden | Compounded | $349 flat (some plans $450) | None | Flat all-dose pricing |
| Willow | Compounded | From $399 | Varies | Flat-leaning pricing, verify pharmacy |
| Noom Med | Compounded + brand | $149 to $499 | Program fee | Coaching-heavy, wide price spread |
| Calibrate | Brand | $299 program fee + medication | $299/mo (annual) | Coaching program, medication billed separately |
| WeightWatchers Med+ | Brand Zepbound | ~$523 ($74 + Zepbound) | $74/mo | Brand path, established platform |
| TrimRx | Compounded | $349 all-inclusive | Bundled | Flat all-in pricing |
| Found | Compounded + brand | Membership + medication | ~$99 to $149/mo | Coaching plus medication, confirm pharmacy |
| Empower Pharmacy | 503B outsourcing facility | Rx-routed (not direct-to-consumer) | N/A | FDA-registered 503B, fills via your prescriber |
| Olympia Pharmacy | 503A/503B compounder | Rx-routed via prescriber | N/A | Established compounder, prescriber-routed |
| Strive Pharmacy | 503A compounder | Rx-routed via prescriber | N/A | Patient-specific 503A compounding |
| Brello | Compounded | Quote on consult | Membership | Smaller brand, verify named pharmacy |
| Healthon | Compounded | Quote on consult | Varies | Smaller brand, verify named pharmacy |
| Piper | Compounded | Quote on consult | Membership | Mixed public reviews, verify pharmacy |
If you want the curated short list rather than the full directory, our editors rank the strongest options on the best online GLP-1 program page, and the lowest verified prices live on cheapest tirzepatide.
How tirzepatide pricing actually works
Three line items, not one. Almost every "tirzepatide cost" number you see online quotes a single piece of a three-part bill. Read all three before you compare.
- Medication cost. The drug itself, either compounded tirzepatide or brand Zepbound or Mounjaro. This is the number most ads show.
- Membership or subscription fee. A recurring platform charge that buys you the prescriber visit and refills. Some providers fold it into the medication price. Others bill $74 to $149 a month on top.
- Labs, consults, and shipping. A few programs require baseline bloodwork or charge for shipping. All-in providers include these. Coaching programs sometimes do not.
A "$299" headline next to a hidden "$149 membership" is really $448. That is the trap the comparison table above is built to expose. When a provider advertises a flat, all-in monthly price with no separate membership, your math gets simple and usually cheaper.
Brand path: Zepbound, Mounjaro and LillyDirect
Brand is the most trusted, not the cheapest. Tirzepatide is the active molecule in Eli Lilly's Mounjaro (approved for type 2 diabetes) and Zepbound (approved for weight loss and obstructive sleep apnea). Buying the branded pen or vial means buying directly from the manufacturer's supply chain, with full FDA oversight behind every dose.
Cash prices without insurance break down like this:
- LillyDirect self-pay Zepbound vials: $299/mo at 2.5mg and 5mg, $399/mo at 7.5mg and 10mg, $449/mo at 12.5mg and 15mg. No insurance needed.
- Zepbound brand list price: about $1,086 a month. Mounjaro list is about $1,080 a month.
- Retail pharmacy Zepbound (CVS, Walgreens): roughly $499 to $599 a month with cash discounts.
- Mounjaro retail: about $1,069 to $1,112 a month across doses.
If you carry commercial insurance that covers Zepbound, the Lilly Savings Card can cut your copay to roughly $25 a month for on-label use. That is the single biggest discount available, but it does not apply to Medicare, Medicaid, or weight-loss prescriptions that your plan excludes.
Compounded tirzepatide cost and the dose-tier trap
Compounding is where the savings live. A compounding pharmacy mixes tirzepatide to a prescription, which historically priced well below brand. Across providers, compounded tirzepatide ranges from about $125 to $699 a month. The spread is wide because providers price three different ways.
| Pricing model | Typical range | What to watch |
|---|---|---|
| Flat all-dose | $125 to $349 | Best value; price stays the same as you titrate up |
| Dose-tiered | $99 starter to $699 maintenance | Low intro price, jumps at 10mg to 15mg |
| Membership + medication | $79 fee + $199 to $399 drug | Add the two lines to get your real cost |
Here is the trap competitors gloss over. The dose that delivered the headline results, up to 22.5% average body-weight reduction over 72 weeks in the SURMOUNT-1 trial, was 10mg to 15mg. Many telehealth brands advertise the 2.5mg starter price, then quietly raise the bill once you reach that therapeutic maintenance dose. Flat all-dose providers like Yucca, Trimi, Eden, and TrimRx charge the same at every step, so the price you start with is the price you keep. For the full titration math, see our how to get tirzepatide walkthrough.
Per-provider cost and reviews
Names matter when you are searching by brand. Short profiles for the providers people look up most.
Yucca Health. Flat compounded tirzepatide from $146 to $258 a month, no separate membership, with a named US pharmacy and doctor supervision. The all-in structure and flat dosing make it our top-graded value pick.
Ro (Ro Body). A brand-only path. You pay a $145 to $149 monthly membership, then Zepbound on top, often around $299 for self-pay vials, for a combined cost that can reach roughly $544 a month. Strong platform, but you are paying brand prices.
Hims & Hers. $149 a month membership, discounted to $39 the first month, plus Zepbound from about $299. Hims has also offered compounded options. A public company with a polished app, priced in the mid-to-premium tier.
Henry Meds. Oral and injectable compounded tirzepatide, commonly $297 to $349 a month, with starter pricing around $99 to $119. One of the most reviewed names in the space.
Mochi Health. A $79 monthly membership plus compounded tirzepatide, frequently landing near $278 all-in, or $199 to $299 depending on plan. Known for working with insurance where possible.
Remedy Meds. Flat $399 a month for compounded tirzepatide with no separate membership fee. Simple, mid-range pricing.
Eden. Flat $349 a month at all doses on most plans, with some plans quoted near $450. The flat structure sidesteps the dose-tier trap.
Willow. Compounded tirzepatide from $399 a month. Confirm which pharmacy fills your prescription before you commit.
Noom Med. A coaching-first platform with a wide $149 to $499 monthly range depending on whether you are on compounded or brand and how much program support you add.
MEDVi. Offers both brand (Zepbound, Wegovy) and compounded tirzepatide and semaglutide, $99 to $399 a month, with no membership fee on compounded plans.
Smaller brands (Brello, Healthon, Piper). These appear in per-brand searches but publish less pricing. Treat any quote as provisional, ask which pharmacy fills the order, and confirm the prescriber is licensed in your state. Aggregate review counts are thin compared with the larger names, so weigh that before paying upfront.
For a deeper read on real patient outcomes across brands, see our tirzepatide reviews roundup.
The pharmacies behind the brands: 503A vs 503B
You are often buying from a pharmacy, not a brand. Telehealth platforms route your prescription to a compounding pharmacy, and the pharmacy's category tells you a lot about safety and oversight. The FDA recognizes two.
- 503A pharmacies compound patient-specific prescriptions, regulated mainly by state boards. Examples include Olympia and Strive. They fill one order at a time for a named patient.
- 503B outsourcing facilities register with the FDA, follow current good manufacturing practice, and can batch-produce. Empower Pharmacy is a large 503B. These face stricter federal oversight and batch testing.
People search the pharmacy name directly, like Empower, Olympia, or Strive, but these pharmacies do not sell tirzepatide direct to consumers. You reach them through a prescriber or telehealth platform. If you want to understand the legal status of compounded supply right now, our tirzepatide compounding pharmacy page tracks it in detail.
How to spot a legitimate provider vs red flags
Cheapest is not the same as safe. The lowest number on a directory means nothing if the pharmacy is anonymous. Use this checklist on any provider before you pay.
Green flags:
- Names the specific US pharmacy that fills your prescription (503A or 503B).
- Requires a real prescriber visit and an intake before dispensing.
- Publishes batch or third-party testing and certificates of analysis.
- Sources from a US pharmacy, not an overseas shipper.
- Shows a single all-in price with no surprise membership at checkout.
Red flags:
- Sells without any prescription or medical intake.
- Will not name the pharmacy or dodges the question of who fills your prescription.
- Ships from outside the US with no pharmacy license.
- Prices that look too low to be real, with no batch testing.
The FDA has warned about unapproved and counterfeit GLP-1 products sold outside the legitimate supply chain. Read the agency's notice on the risks of unapproved GLP-1 drugs before you buy from any seller you cannot verify.
FDA enforcement reshaped compounded supply
The rules changed in 2025. Compounded tirzepatide was widely available while the drug sat on the FDA shortage list. Once the agency declared the tirzepatide shortage resolved in early 2025, the legal basis for mass compounding under the shortage exception closed, and enforcement followed. Some brands, including Trimi, paused compounded supply during that transition.
Legitimate compounded tirzepatide still exists, but mostly through patient-specific 503A compounding for a documented clinical reason, such as an allergy to an inactive ingredient or a dose not commercially available. That is why provider legitimacy, not price, is now the first thing to check.
Insurance, prior authorization and savings
Insurance can beat every cash price, when it applies. If your commercial plan covers Zepbound or Mounjaro, the Lilly Savings Card can bring your copay to about $25 a month for on-label use. The catch is coverage. Many plans require prior authorization, where your prescriber documents a qualifying BMI or diagnosis before the plan pays.
Medicare is the hard case. Under current rules, Medicare Part D generally cannot cover a drug used only for weight loss, so Zepbound for obesity alone is usually excluded. Coverage may apply when tirzepatide is prescribed for an approved condition such as type 2 diabetes (Mounjaro) or obstructive sleep apnea (Zepbound). If insurance is your real barrier, our guide to GLP-1 cost without insurance maps every cash-pay route.
Why tirzepatide costs more than semaglutide
You pay more for a second target. Tirzepatide is a dual GIP/GLP-1 agonist, hitting two gut-hormone receptors, while semaglutide acts on GLP-1 alone. That extra mechanism is harder and costlier to make, which is why telehealth providers price tirzepatide roughly $50 to $150 a month above semaglutide.
The premium buys measurably more weight loss. In the head-to-head SURMOUNT-5 trial, tirzepatide produced 20.2% average body-weight reduction over 72 weeks versus 13.7% for semaglutide. For the full side-by-side on dosing, side effects, and value, see tirzepatide vs semaglutide.
12-month total cost
Annualize before you decide. A $146 flat compounded plan is about $1,752 a year. LillyDirect Zepbound vials, climbing from $299 to $449 as you titrate, land near $4,500 to $5,000 for a year. Brand at full retail without any discount can exceed $13,000 a year. Insurance with the savings card, when it applies, can drop a year to roughly $300.
The lesson is simple. For most cash-pay patients, a flat all-in compounded plan from a verified provider is the lowest total-cost path, and brand makes sense when insurance and the savings card bring it within reach.
Frequently Asked Questions
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022. pubmed.ncbi.nlm.nih.gov.
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine, 2025. pubmed.ncbi.nlm.nih.gov.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov.
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. fda.gov.
- U.S. Food and Drug Administration. Drugs@FDA: Zepbound (tirzepatide), NDA 215866. accessdata.fda.gov.
- Centers for Medicare & Medicaid Services. Prescription Drug Coverage (Part D). cms.gov.
- Eli Lilly. LillyDirect self-pay pharmacy. lillydirect.com.
- Eli Lilly. Zepbound coverage and savings. zepbound.lilly.com.
